Key Insights

Highlights

Success Rate

85% trial completion

Published Results

30 trials with published results (34%)

Research Maturity

51 completed trials (57% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

10.1%

9 terminated out of 89 trials

Success Rate

85.0%

-1.5% vs benchmark

Late-Stage Pipeline

25%

22 trials in Phase 3/4

Results Transparency

59%

30 of 51 completed with results

Key Signals

30 with results85% success

Data Visualizations

Phase Distribution

81Total
Not Applicable (37)
Early P 1 (1)
P 1 (6)
P 2 (15)
P 3 (11)
P 4 (11)

Trial Status

Completed51
Unknown15
Terminated9
Recruiting8
Withdrawn2
Active Not Recruiting2

Trial Success Rate

85.0%

Benchmark: 86.5%

Based on 51 completed trials

Clinical Trials (89)

Showing 20 of 20 trials
NCT07476053Not ApplicableRecruitingPrimary

Light Exposure, Migraine Outcomes, and Sleep Quality

NCT06874361Not ApplicableCompleted

Cooling to Alleviate Migraine #3

NCT07292090Not ApplicableRecruiting

Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD - a Pilot Study

NCT07348783Not ApplicableNot Yet Recruiting

Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD

NCT07295587Enrolling By InvitationPrimary

Assessment of the Impact of Headache on the Employee Population of Libbs Pharmaceutical Ltd

NCT07292506Not ApplicableActive Not Recruiting

The Impact of Acupuncture on Biomarkers of Brain Injury and Inflammatory Response in Migraine

NCT06203873Not ApplicableRecruiting

A Comparison of Biodegradable and Metal Occluders in Patients With PFO and Migraine

NCT05943457Not ApplicableRecruitingPrimary

Vitamin K2 Supplementation in Adult Episodic Migraine

NCT07015125Not ApplicableCompleted

Evaluation of a Wearable Device for Acute Treatment of Migraines

NCT03971071Phase 4CompletedPrimary

A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache

NCT07022496Phase 4Recruiting

Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals

NCT07015411Not ApplicableRecruitingPrimary

Neuro-Complex & Multi Supplements for Migraine Prevention

NCT05780671CompletedPrimary

Oxygen in Migraine Treatment

NCT01630044Not ApplicableCompletedPrimary

Neurostimulation Device for Treatment of Migraine Headache

NCT06798259Active Not RecruitingPrimary

Autonomic Dysfunction in Patients With Migraine: Cardiovascular and Neurophysiology Assessment

NCT03097536Not ApplicableTerminatedPrimary

Migraine and Homeostasis:What Can we Learn From Glucose

NCT04389372Phase 4CompletedPrimary

Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients with Chronic Migraine and Medication Overuse

NCT06674772Recruiting

Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification

NCT04084314Phase 4Completed

Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study

NCT04613362Not ApplicableCompletedPrimary

TelemEdiciNe-bAsed Cognitive TherapY for Migraines

Scroll to load more

Research Network

Activity Timeline